---
figid: PMC5597737__rstb20160270-g1
figlink: /pmc/articles/PMC5597737/figure/RSTB20160270F1/
number: F1
caption: Activation of NF-κB and IL6/STAT3 signalling pathways in NPC cells by multiple
  EBV-encoded latent gene products. Through binding with TLR3, abundant EBERs could
  strongly activate both NF-κB and IFN3 signalling pathways. However, the inactivation
  of TRAF3 by either LMP1 expression or somatic mutation will inhibit IFN3 signalling,
  thus protecting the cells from the EBER-induced innate immune response. LMP1 also
  activates the NF-kB signalling pathways through interacting with multiple TRAFs.
  Distinct NF-κB signals, including p50/p50/BCL3 and p50/RelB, will induce multiple
  survival genes (A20, survivin) and inflammatory cytokines (IL6). EBNA1 induces the
  ubiquitous expression of IL6R in NPC cells. The binding of highly expressed IL6
  with IL6R results in constitutive activated STAT3 signalling. The activated STAT3
  pathway might crosstalk with the altered NF-κB signalling by the upregulation of
  BCL3 in NPC cells. The common somatic mutations in NPC targeting the NF-κB pathways
  are also shown.
pmcid: PMC5597737
papertitle: Epstein–Barr virus infection and nasopharyngeal carcinoma.
reftext: Sai Wah Tsao, et al. Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):20160270.
pmc_ranked_result_index: '6513'
pathway_score: 0.9570314
filename: rstb20160270-g1.jpg
figtitle: Activation of NFKB and IL6/STAT3 signalling pathways in NPC cells by multiple
  EBV-encoded latent gene products
year: '2017'
organisms: Homo sapiens
ndex: 1758fa0f-dee7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5597737__rstb20160270-g1.html
  '@type': Dataset
  description: Activation of NF-κB and IL6/STAT3 signalling pathways in NPC cells
    by multiple EBV-encoded latent gene products. Through binding with TLR3, abundant
    EBERs could strongly activate both NF-κB and IFN3 signalling pathways. However,
    the inactivation of TRAF3 by either LMP1 expression or somatic mutation will inhibit
    IFN3 signalling, thus protecting the cells from the EBER-induced innate immune
    response. LMP1 also activates the NF-kB signalling pathways through interacting
    with multiple TRAFs. Distinct NF-κB signals, including p50/p50/BCL3 and p50/RelB,
    will induce multiple survival genes (A20, survivin) and inflammatory cytokines
    (IL6). EBNA1 induces the ubiquitous expression of IL6R in NPC cells. The binding
    of highly expressed IL6 with IL6R results in constitutive activated STAT3 signalling.
    The activated STAT3 pathway might crosstalk with the altered NF-κB signalling
    by the upregulation of BCL3 in NPC cells. The common somatic mutations in NPC
    targeting the NF-κB pathways are also shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - STAT2
  - TYK2
  - JAK3
  - JAK1
  - RELB
  - STAT1
  - TRAF2
  - TRAF3
  - JAK2
  - TLR3
  - NFKBIA
  - STAT5B
  - STAT6
  - STAT3
  - IL6
  - TNFAIP3
  - BCL3
  - CYLD
  - IKBKB
  - TRAF6
  - IRF3
  - IL6R
  - STAT5A
  - IKBKG
  - STAT4
  - CHUK
  - KCNK18
  - IKBKE
  - Rheumatoid arthritis
genes:
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: RELB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TLR3
  symbol: TLR3
  source: hgnc_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: BCL3
  symbol: BCL3
  source: hgnc_symbol
  hgnc_symbol: BCL3
  entrez: '602'
- word: CYLD
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: IRF3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: IL6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: IKKa
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: TRIK
  symbol: TRIK
  source: hgnc_alias_symbol
  hgnc_symbol: KCNK18
  entrez: '338567'
- word: IKKE
  symbol: IKKE
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKE
  entrez: '9641'
chemicals: []
diseases:
- word: Rheumatoid arthritis
  source: ''
  identifier: ''
figid_alias: PMC5597737__F1
redirect_from: /figures/PMC5597737__F1
figtype: Figure
---
